GENEVA, March 31 -- XELLSMART BIO-PHARMACEUTICAL (SUZHOU) CO., LTD. (Unit 201, Building 3, Zone B, Biomedical Industrial Park Phase 3, 99 Jingu Road, Suzhou Industrial ParkSuzhou, Jiangsu 215332), 士泽生物医药(苏州)有限公司 (中国江苏省苏州市苏州工业园区金谷路99号生物医药产业园三期B区项目3号楼201单元) filed a patent application (PCT/CN2024/120109) for "LOW-IMMUNOGENICITY CELL EXPRESSING MCL1 AND PREPARATION METHOD THEREFOR" on Sep 20, 2024. With publication...